Cardiff Oncology (CRDF) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.28
-0.26
-0.23
-0.21

Details

Expected EPS
-0.2475
Actual EPS
-0.26
Surprise EPS
-0.01
Surprise Percent
+5.05%

Description

Cardiff Oncology (CRDF) has reported earnings of -0.26 per share for Q3 2024.

0 Comments

Share your thoughts